Zobrazeno 1 - 10
of 325
pro vyhledávání: '"De‐Pei Wu"'
Autor:
Qian Wu, Xiaofei Yang, Jingren Zhang, Mengxing Xue, Xueqing Dou, Zheng Ge, Yifei Chen, Weiying Gu, Weimin Dong, Hongying Cao, Naike Jiang, Xuemei Sun, Zefa Liu, Jinning Shi, Hui Chen, Cixian Zhang, Fengling Min, Hongli Sun, Xiaoli Qian, Hongjian Yuan, Yuan Feng, De-Pei Wu, Suning Chen
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-5 (2024)
Externí odkaz:
https://doaj.org/article/7f0590faf80946ff9d03c7d60b125b76
Autor:
Jin‐Feng Ma, Jia‐Wei Yan, Mei‐Jing Liu, Chun‐Long Yan, Xiao‐Wen Tang, Hui‐Ying Qiu, Miao Miao, Yue Han, Li‐Min Li, Li‐Qing Kang, Nan Xu, Zhou Yu, Jing‐Wen Tan, Hong‐Jia Zhu, Xu Jia, Zhi‐Zhi Zhang, Miao Wang, Hai‐Ping Dai, Lei Yu, Sheng‐Li Xue, De‐Pei Wu, Wen‐Jie Gong
Publikováno v:
HemaSphere, Vol 8, Iss 10, Pp n/a-n/a (2024)
Abstract Severe cytokine release syndrome (sCRS) and immune effector cell‐associated neurotoxicity syndrome (ICANS) have limited the widespread use of chimeric antigen receptor T (CAR T)‐cell therapy. We designed a novel anti‐CD19 CAR (ssCART
Externí odkaz:
https://doaj.org/article/e8bd78da2b4d4b95bc0187ea88dc722c
Autor:
Yu Wang, Qi-Fa Liu, De-Pei Wu, Zheng-Li Xu, Ting-Ting Han, Yu-Qian Sun, Fen Huang, Zhi-Ping Fan, Na Xu, Feng Chen, Ye Zhao, Yuan Kong, Xiao-Dong Mo, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background There is an urgent unmet need for effective initial treatment for acute graft-versus-host disease (aGVHD) adding to the standard first-line therapy with corticosteroids after allogeneic haematopoietic stem cell transplantation (al
Externí odkaz:
https://doaj.org/article/fadebd47410447edb47679dca8895cf5
Autor:
Miao Wang, Han-Yu Cao, Kai-Wen Tan, Qiao-Cheng Qiu, Yuan-Hong Huang, Shuai-shuai Ge, Zi-Hao Wang, Jia Chen, Xiao-Wen Tang, De-Pei Wu, Sheng-Li Xue, Zheng Li, Hai-Ping Dai
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/638f511fdb7145c0811514bbb3eea81b
Publikováno v:
eJHaem, Vol 4, Iss 4, Pp 1208-1211 (2023)
Abstract Adverse‐risk acute myeloid leukemia (AML) has a dismal prognosis. We aimed to investigate the activity and tolerability of venetoclax combined with homoharringtonine (HHT) plus cytarabine (VHA) regimen for de novo adverse‐risk AML. Thirt
Externí odkaz:
https://doaj.org/article/85765016e8c84875826729e1f203e4bf
Autor:
Yu-Qi Zhang, Wen-Qi Wu, Jie Xu, Zai-Xiang Tang, Shi-Jia Li, Ling Li, He-Qing Wu, Xiao Ma, Ji-Sheng Liu, De-Pei Wu, Xiao-Jin Wu
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 2 (2024)
ABSTRACTThe purpose of this study is to establish a clinical prediction model to discriminate patients at high risk of Klebsiella pneumoniae (KP) colonization before allogeneic hematopoietic stem cell transplantation (allo-HSCT) and evaluate the impa
Externí odkaz:
https://doaj.org/article/b5b9ba90f497426887d0ba5e889fff02
Autor:
Jing-Ying Zou, Si-Man Huang, Hai-Xia Zhoub, Ming-Zhu Xu, Ai-Ning Sun, De-Pei Wu, Sheng-Li Xue, Tong-Tong Zhang
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjectives: Venetoclax has shown synergism with BCR-ABL1 tyrosine kinase inhibitors (TKIs) in preclinical studies for patients with Philadelphia chromosome-positive (Ph+) leukemias. This combination may suggest a novel treatment strategy for
Externí odkaz:
https://doaj.org/article/f1cfee49a2964707ab25a52fd8865ca5
Autor:
Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, Hai-Xia Zhou, Mei-Jing Liu, Wen-Jie Gong, Li-Qing Kang, Ai-Ning Sun, Lei Yu, De-Pei Wu, Chong-Sheng Qian, Sheng-Li Xue
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/5ac399e240104f459bc6058032c3c523
Autor:
Hai-ping Dai, Dan-qing Kong, Hong-jie Shen, Wei Cui, Qian Wang, Zheng Li, Jia Yin, Li-qing Kang, Lei Yu, De-pei Wu, Xiao-wen Tang
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-6 (2023)
Abstract It was previously believed that patients with Ph-like ALL had poorer prognosis compared with other B-ALL subgroups due to resistance to conventional chemotherapy and lack of targeted drugs. CAR-T therapy has been successfully applied in the
Externí odkaz:
https://doaj.org/article/4ebc7dc77ce14d0d9c31d3f09b88ad11
Autor:
Chang-Ju Qu, Rui Zou, Jia-Jie He, Na-Na Ping, Qian Zhu, Xiao Zhang, Fan Xia, Danqing Kong, De-Pei Wu, Zheng-Ming Jin
Publikováno v:
HemaSphere, Vol 7, p e9345820 (2023)
Externí odkaz:
https://doaj.org/article/5e0e46b354944c81a37a334a67c40806